Immunome Inc.
IMNMNasdaqCIK 1472012HealthcareFiscal year ends Dec 31
Reports and events: 124 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0508:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-413217 |
| 2026-08-1116:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-344636 |
| 2026-08-1116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344577 |
| 2026-06-1216:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-269383 |
| 2026-05-1216:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219425 |
| 2026-05-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219367 |
| 2026-04-2416:05 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001140361-26-016685 |
| 2026-03-0316:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-088172 |
| 2026-03-0316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-088141 |
| 2025-12-2221:22 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001953107-25-000019 |
| 2025-12-1716:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-322877 |
| 2025-12-1507:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-318429 |
| 2025-11-0616:18 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269603 |
| 2025-11-0616:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269538 |
| 2025-08-0616:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104035 |
| 2025-08-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104015 |
| 2025-06-1116:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-058523 |
| 2025-05-1216:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007382 |
| 2025-05-1216:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-047304 |
| 2025-04-2416:05 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001140361-25-015421 |
| 2025-03-1916:11 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003302 |
| 2025-03-1916:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-025558 |
| 2025-02-0417:44 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-002988 |
| 2025-01-3016:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-007610 |
| 2025-01-2916:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001104659-25-007198 |
| 2025-01-2316:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-005594 |
| 2024-11-1316:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015524 |
| 2024-11-1316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-117682 |
| 2024-10-2908:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-112053 |
| 2024-10-0819:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-106777 |
| 2024-08-2116:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001123292-24-000228 |
| 2024-08-1216:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011898 |
| 2024-08-1216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-088340 |
| 2024-06-1316:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-071253 |
| 2024-05-1408:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-008066 |
| 2024-05-1408:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-060893 |
| 2024-04-3016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-054910 |
| 2024-04-2616:05 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001140361-24-022426 |
| 2024-04-2516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-051944 |
| 2024-03-2816:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-004247 |
| 2024-03-2816:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-040503 |
| 2024-03-2608:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-038744 |
| 2024-02-1416:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-023641 |
| 2024-02-1316:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-019883 |
| 2024-02-0608:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-010945 |
| 2024-02-0121:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-009012 |
| 2024-01-1117:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-003380 |
| 2024-01-0807:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-002059 |
| 2024-01-0208:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-000121 |
| 2023-12-2917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-130516 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:06 ET. Listed shows no prices and gives no investment advice.